DEA Registration for State-Licensed Medical Cannabis Businesses
Updated October 21, 2026
Since April 28, 2026, marijuana handled under a state medical cannabis license has been in Schedule III of the federal Controlled Substances Act, and DEA registration is how a licensed medical business takes part in that federal system. Drivon Consulting helps dispensaries, manufacturers, distributors and testing labs plan, file and keep their DEA registrations, in California and in other states that license medical cannabis.
Book a consultation or call (209) 636-4856 to review your licenses and locations before you apply.
What changed in 2026
- April 28, 2026: A final order published in the Federal Register moved FDA-approved marijuana products, and marijuana subject to a state medical marijuana license, from Schedule I to Schedule III. Marijuana outside those two groups, including adult-use marijuana, remains in Schedule I.
- The same order lets state-licensed medical businesses register with DEA to manufacture, distribute or dispense. A DEA registration cannot go beyond the scope of the state license, and it is automatically suspended if that license is suspended, revoked or expires.
- June 2026: The 60-day expedited window for early applicants closed. Dispensaries can still apply.
- October 5, 2026: DEA opened its Form 225 application for medical marijuana manufacturers, distributors and analytical labs.
- A separate DEA proceeding on moving all marijuana, including adult-use, to Schedule III is still pending. The administrative law judge stayed it on September 29, 2026.
Which DEA registration fits your business
| Your state-licensed activity | DEA registration | What to know |
|---|---|---|
| Dispensary (retail to patients) | Dispenser, DEA Form 224 | DEA directs medical marijuana dispensaries to its dispensary registration portal. The expedited window has closed, but applications are still accepted. |
| Cultivation and manufacturing (cultivate, produce, process, package, label) | Manufacturer, DEA Form 225 | Manufacturers also set a nominal price for their crops, which DEA buys and resells to them, and must store crops where DEA has access. |
| Distribution | Distributor, DEA Form 225 | DEA opened a dedicated medical marijuana application on October 5, 2026. |
| Testing laboratory | Analytical lab, DEA Form 225 | DEA opened a dedicated medical marijuana application on October 5, 2026. |
DEA requires a separate registration for each principal place of business where controlled substances are manufactured, distributed or dispensed, so operators with several sites should plan one registration per site.
How we help
- Eligibility and filing plan. We match each of your state licenses and locations to the right DEA registration, and work out how medical and adult-use activity is structured before anything is filed.
- Readiness review. We confirm your state licenses are current and in good standing, that entity and ownership records match across filings, and that your SOPs, security, inventory and track-and-trace records are in order.
- Key personnel history. The application asks about convictions and past license or registration actions for the business and its officers, partners and stockholders. We gather that history early and prepare clear, accurate answers with you.
- Preparing and filing. We assemble the Form 224 or Form 225 application, your state license details and supporting documents, and follow the application through DEA.
- Manufacturer requirements. We help set up the crop pricing, storage access and cultivation-area details that only manufacturer registrations carry.
- DEA inspections and questions. We prepare your team and records for DEA site visits and information requests.
- Keeping the registration. A DEA registration is suspended when the state license lapses, so we tie state renewals, license changes and DEA records together.
Registering outside California
DEA registration is a federal process, and the same rules apply in every state that licenses medical cannabis. We work with medical operators across the U.S. on their DEA filings, and coordinate with local counsel on questions of state law.
Medical and adult-use operators
The April order covers medical activity only. Adult-use marijuana is still in Schedule I, and a DEA registration does not authorize non-medical activity. The Form 225 application asks whether a business handles medical marijuana, recreational marijuana or both. If you hold both kinds of licenses, decide how the business and its licenses are structured before you file, together with your legal and tax advisors.
Common questions
Is the 60-day expedited window still open?
No. It ran for 60 days after the order was published on April 28, 2026, and closed in June 2026. Dispensaries can still apply, and DEA opened a dedicated Form 225 application for manufacturers, distributors and labs on October 5, 2026.
Does Schedule III cover adult-use cannabis?
Not yet. Only FDA-approved products and marijuana subject to a state medical license moved to Schedule III. A separate DEA proceeding on broader rescheduling is pending, and it was stayed on September 29, 2026.
What happens to my DEA registration if my state license lapses?
It is automatically suspended if the state medical license is suspended, revoked or expires. A DEA registration also cannot cover more than the state license does.
Do I need a separate registration for each location?
Yes. DEA requires a separate registration for each principal place of business where controlled substances are manufactured, distributed or dispensed.
Does DEA registration affect Section 280E?
Section 280E applies only to Schedule I and II substances, so Schedule III status matters for qualifying medical businesses. Practitioners disagree on whether DEA registration is needed to claim that relief. We coordinate with your tax advisor, and nothing on this page is tax advice.
Can you help businesses outside California?
Yes. DEA registration is federal, so we work with medical operators in any state that licenses medical cannabis, and coordinate with local counsel on state-law questions.
Sources
- Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements, 91 FR 22714, Federal Register, April 28, 2026
- DEA Opens New Schedule III Registration Portal for Medical Cannabis Manufacturers, Distributors, Labs, Cannabis Business Times, October 5, 2026
- DEA Judge Pauses Marijuana Rescheduling Hearing Over New GAO Report, Vicente LLP, September 30, 2026
- 21 CFR 1301.12, Separate registrations for separate locations, Legal Information Institute
- DEA Diversion Control Division
This page is general information about DEA registration, not legal or tax advice for your business.